BURLINGAME, CA, UNITED STATES, February 5, 2025 /EINPresswire / -- The Pen Needles Market Report is the result of extensive research and analysis conducted by our team of experienced market ...

Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...

The company's blockbuster semaglutide drugs, Wegovy for weight loss and Ozempic for diabetes ... Injection pens and boxes of Novo Nordisk's weight-loss drug Wegovy are shown in this photo ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling ... latest numbers can move the needle in a competitive market.

Ozempic and Rybelsus are marketed by Novo Nordisk for treatment of type 2 diabetes, while Wegovy is marketed for weight loss. Ozempic and Wegovy are both weekly injections. Ozempic is sold in ...